Newly released data show that Poland is home to over 9,261 patients legally accessing medical cannabis, making it one of the largest such populations in Europe. Currently, legislative work is taking place with respect to six different drafts of amendments to the hemp law, two of which relate to the legalisation of recreational use. The […]
Symtomax Portugal, a medical cannabis operator, has announced that it has been granted approval to commence cultivation from INFARMED, the Portuguese regulatory authority for the pharmaceutical industry in Portugal. Symtomax was established in 2017 with a commitment to advancing alternative and effective products to improve the health and well-being of people. The license will allow […]
A strictly limited number of Early Bird Tickets are now available at a special price of $595 – a saving of $100 on Advanced Tickets, and a saving of $200 on Final Release tickets. The combined network of Prohibition Partners and Business of Cannabis boasts some of the biggest brands and businesses in cannabis – and beyond. Cannabis remains illegal in […]
The European Monitoring Centre for Drugs and Drug Addiction says the THC content of cannabis resin is now on average between 20% and 28% – almost twice that of cannabis flower. Its annual trends and development report draws on information provided by EU member states, as well as Turkey and Norway, and presents a top-level […]
Argentina, historically one of the most developed and educated countries in Latin America, is today faced with a stagnant economy and an uncertain future, after years of political and economical struggles. Neighbouring Uruguay is a country with a very close cultural relationship with Argentina and legalised both medical and adult-use cannabis in 2013. Being a […]
Both parties are essentially proposing that the cultivation, distribution, purchasing, possession and consumption of adult-use cannabis should be legalised. The major difference between both Bills is that the Left Bloc party is proposing State control of the entire circuit of cultivation, production and distribution – including a register of all users. Another key difference between […]
Medical cannabis is becoming increasingly liberalised across Europe, especially in high-income western countries such as Germany, the Netherlands, Italy and Switzerland. Outdated laws around access to medical cannabis are still preventing patients from obtaining legal medical products other than a limited set of pharmaceutical cannabinoid products such as Sativex and Epydiolex. As such, the creation […]
In order to best serve the medical cannabis patient population in Europe, operators need an understanding of who the patients are and why they rely on these medicines. Prohibition Partners has gathered data for European medical cannabis patients from national government agencies and independent research groups to investigate high-level statistics on patients being prescribed medical […]